English   español  

Browsing by Author Bautista-Aguilera, Óscar M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 16 of 16
RightsPreviewIssue DateTitleAuthor(s)Type
2020Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer's Disease TherapyBautista-Aguilera, Óscar M.; Ismaili, Lhassane; Chioua, Mourad CSIC ORCID ; Andrys, R.; Schmidt, Monika; Bzonek, Petr; Martínez-Grau, Angeles; Beadle, C. D.; Vetman, T.; López-Muñoz, Francisco; Iriepa, Isabel; Refouvelet, Bernard; Musilek, Kamil; Marco-Contelles, José CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2020Automated Synthesis of New QuinoxalinetacrinesBautista-Aguilera, Óscar M.; Ismaili, L.; Chioua, Mourad CSIC ORCID ; Iriepa, Isabel; Martínez-Grau, Angeles; Beadle, C. D.; Vetman, T.; López-Muñoz, Francisco; Marco-Contelles, José CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2018Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism ProfileBautista-Aguilera, Óscar M.; Budni, J.; Mina, F.; Medeiros, E. B.; Deuther-Conrad, W.; Entrena, J. M.; Moraleda, I.; Iriepa, Isabel; López-Muñoz, F.; Marco-Contelles, José CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2014Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's diseaseBautista-Aguilera, Óscar M.; Esteban, Gerard; Bolea, Irene; Nikolic, Katarina; Agbaba, Danica; Moraleda, Ignacio; Iriepa, Isabel; Samadi, Abdelouahid CSIC ORCID; Soriano, Elena CSIC; Unzeta, Mercedes; Marco-Contelles, José CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2015Development of HuperTacrines as non-toxic, cholinesterase inhibitors for the potential treatment of Alzheimer’s diseaseChioua, Mourad CSIC ORCID ; Pérez, Marta M.; Bautista-Aguilera, Óscar M.; Yáñez, M.; López, M. G.; Romero, A.; Cacabelos, Ramón; Bellacasa, R. P. de la; Brogi, S.; Butini, S.; Borrell, J. I.; Marco-Contelles, José CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2014Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's diseaseWang, L.; Esteban, Gerard; Ojima, Masaki; Bautista-Aguilera, Óscar M.; Inokuchi, Tsutomu; Moraleda, Ignacio; Iriepa, Isabel; Samadi, Abdelouahid CSIC ORCID; Youdim, Moussa B. H.; Romero, Alejandro CSIC ORCID; Soriano, Elena CSIC; Herrero, Raquel; Fernández Fernández, Ana Patricia CSIC ORCID; Martínez-Murillo, Ricardo CSIC ORCID; Marco-Contelles, José CSIC ORCID; Unzeta, Mercedesartículo
openAccessDrug Design, Development and Therapy.pdf.jpg2014Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease: Design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybridsBautista-Aguilera, Óscar M.; Esteban, Gerard; Chioua, Mourad CSIC ORCID ; Nikolic, Katarina; Agbaba, Danica; Moraleda, Ignacio; Iriepa, Isabel; Soriano, Elena CSIC; Samadi, Abdelouahid CSIC ORCID; Unzeta, Mercedes; Marco-Contelles, José CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2017Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative DiseasesBautista-Aguilera, Óscar M.; Hagenow, S.; Palomino-Antolín, Alejandra; Farré-Alins, V.; Ismaili, L.; Joffrin, P. L.; Jimeno, M. Luisa; Soukup, O.; Janockova, Jana; Kalinowski, A.; Proschak, E.; Iriepa, Isabel; Moraleda, I.; Schwed, J. S.; Romero Martínez, Alejandro; López-Muñoz, Francisco; Chioua, Mourad CSIC ORCID ; Egea, Javier; Ramsay, R. R.; Marco-Contelles, José CSIC ORCID; Stark, H.artículo
closedAccessaccesoRestringido.pdf.jpg2014N-methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitorBautista-Aguilera, Óscar M.; Samadi, Abdelouahid CSIC ORCID; Chioua, Mourad CSIC ORCID ; Nikolic, K.; Filipic, S.; Agbaba, Danica; Soriano, Elena CSIC; Andrés, L. de; Rodríguez-Franco, María Isabel CSIC ORCID ; Alcaro, S.; Ramsay, R. R.; Ortuso, F.; Yáñez, Matilde; Marco-Contelles, José CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2015Predicting targets of compounds against neurological diseases using cheminformatic methodologyNikolic, Katarina; Mavridis, L.; Bautista-Aguilera, Óscar M.; Marco-Contelles, José CSIC ORCID; Stark, H.; do Carmo Carreiras, María; Rossi, I.; Massarelli, P.; Agbaba, Danica; Ramsay, Rona R.; Mitchell, J. B. O.artículo
openAccessmolecules-21-00634.pdf.jpg14-May-2016Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s DiseaseDgachi, Youssef; Bautista-Aguilera, Óscar M.; Benchekroun, M.; Martin, Hélène; Bonet, Alexandre; Knez, Damijan; Godyń, Justyna; Malawska, Bárbara; Gobec, Stanislav; Chioua, Mourad CSIC ORCID ; Janockova, Jana; Soukup, O.; Chabchoub, Fakher; Marco-Contelles, José CSIC ORCID; Ismaili, L.artículo
closedAccessaccesoRestringido.pdf.jpg2016Synthesis, regioselectivity, and DFT analysis of new antioxidant pyrazolo[4,3-c]quinoline-3,4-dionesTomassoli, I.; Herlem, G.; Picaud, F.; Benchekroun, M.; Bautista-Aguilera, Óscar M.; Luzet, V.; Jimeno, M. Luisa; Gharbi, T.; Refouvelet, B.; Ismaili, L.artículo
openAccesstcr.202000107.pdf.jpg2021Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent DevelopmentsBautista-Aguilera, Óscar M.; Ismaili, L.; Iriepa, Isabel; Diez-Iriepa, Daniel; Chabchoub, Fakher; Marco-Contelles, José CSIC ORCID; Pérez-García, Marta CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2016The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 ActivatorsBenchekroun, M.; Romero, A.; Egea, Javier; León, Rafael CSIC ORCID ; Michalska, P.; Buendía, I.; Jimeno, M. Luisa CSIC ORCID; Jun, D.; Janockova, J.; Sepsova, V.; Soukup, O.; Bautista-Aguilera, Óscar M.; Refouvelet, B.; Ouari, O.; Marco-Contelles, José CSIC ORCID; Ismaili, L.artículo
openAccessmolecules-25-03190-v2.pdf.jpg2020Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer's Disease TherapyZribi, L.; Pachón-Angona, I.; Bautista-Aguilera, Óscar M.; Diez-Iriepa, Daniel; Marco-Contelles, José CSIC ORCID; Ismaili, L.; Iriepa, Isabel; Chabchoub, Fakherartículo
closedAccessaccesoRestringido.pdf.jpg2014Wnt signaling pathway, a potential target for Alzheimer's disease treatment, is activated by a novel multitarget compound ASS234Pino, Javier del; Ramos, Eva; Bautista-Aguilera, Óscar M.; Marco-Contelles, José CSIC ORCID; Romero, Alejandro CSIC ORCIDartículo